Subdural Hematoma Clinical Trial
Official title:
TRACE STUDY: A Randomized Controlled Trial Using Tranexamic Acid in the Treatment of Subdural Hematoma
Subdural hematoma (SDH) is a common condition experienced after head injury. Blood collects on the surface of the brain, causing headaches which can progress to confusion, weakness, or even coma. While patients with SDH often receive surgery, not all patients require surgery right away to ease pressure on the brain. After surgery, there can be up to 30 percent chance of more bleeding and the need for more surgeries. Given this, a drug capable of lowering the chance of more bleeding and speeding the recovery of the patient is highly desirable. In this study, we will test a commonly used, cheap drug called Tranexamic Acid (TXA). While the body stops unwanted and sometimes dangerous bleeding naturally by forming blood clots, TXA stops these blood clots from breaking down, which helps to keep bleeding spots plugged. Our previous study showed that TXA helped speed up patients' recovery; but a larger number of patients is necessary to evaluate how well TXA works to reduce bleeding and improve patient-reported outcomes. In this study, regardless of the need for surgery, half of the patients will be randomly assigned to take TXA, while the other half will take a placebo, which is a look-alike substance that contains no active drug. We will measure multiple outcomes over time to determine if TXA is working and lowers healthcare and personal costs, while also taking blood and surgical samples, to better understand how this drug works in SDH patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04402632 -
Embolization of the Middle Meningeal Artery With ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma
|
N/A | |
| Completed |
NCT03496545 -
Efficacy of Bromocriptine For Fever Reduction in Acute Neurologic Injury
|
Phase 1/Phase 2 | |
| Terminated |
NCT05472766 -
Anticoagulation Therapy Timing in Atrial Fibrillation After Acute and Chronic Subdural Hematoma
|
N/A | |
| Not yet recruiting |
NCT06052124 -
Augmented Reality for Subdural Drain Placement
|
N/A | |
| Completed |
NCT02368366 -
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
|
N/A | |
| Terminated |
NCT01463878 -
Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study
|
Phase 4 | |
| Not yet recruiting |
NCT06119932 -
Evaluation of One Burr Hole Evacuation for Subdural Hematoma
|
||
| Completed |
NCT02618382 -
A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population
|
Phase 4 | |
| Recruiting |
NCT04923984 -
Embolization of Middle Meningeal Artery for Subdural Hematoma in Canada (EMMA Can)
|
N/A | |
| Completed |
NCT03153150 -
Start or STop Anticoagulants Randomised Trial (SoSTART)
|
Phase 3 | |
| Completed |
NCT04270955 -
Dartmouth Middle Meningeal Embolization Trial (DaMMET)
|
N/A | |
| Recruiting |
NCT06067750 -
Comparison of Narcotrend and Cerebral Function Analysing Monitor in Intensive Care to Monitor Seizures and Deep Sedation
|
||
| Withdrawn |
NCT01605357 -
Hypernatremia for the Prevention and Treatment of Cerebral Edema in Traumatic Brain Injury
|
Phase 1/Phase 2 | |
| Withdrawn |
NCT04500795 -
Prospective Study on the Use of Middle Meningeal Artery Embolization for Chronic Subdural Haematoma
|
N/A | |
| Recruiting |
NCT04170582 -
Patient Registry for Patients With Chronic Subdural Hematoma
|
||
| Recruiting |
NCT05649904 -
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
|
N/A | |
| Recruiting |
NCT04211233 -
Diagnostic Subdural EEG-electrode And Subdural hEmatoma (DISEASE)
|
N/A |